Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

NCT03267381 · clinicaltrials.gov ↗

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

OTHER: Blood draw (before surgery)
OTHER: Blood draw (every 3 months)
OTHER: Blood draw (at diagnosis)

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]